Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Impaired detrusor contractility: anything new?

Shahar Madjar1, Rodney A Appell

  • 1The Northern Michigan Bladder Control Center, 100 Malton Road, Negaunee, MI 49866, USA. smadjar@yahoo.com

Current Urology Reports
|October 2, 2002
PubMed
Summary

Impaired detrusor contractility (IDC) presents treatment challenges, with clean intermittent catheterization (CIC) as the standard. Novel therapies targeting the nervous system, bladder, or outlet offer alternatives to CIC for managing IDC.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Helping Incontinent Patients Resume Activity.

The Physician and sportsmedicine·2017
Same author

The role of intrinsic sphincteric deficiency diagnosis in the era of midurethral sling.

Current urology reports·2011
Same author

Urethral and bladder injections for incontinence including botox.

The Urologic clinics of North America·2011
Same author

Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status.

International urogynecology journal·2010
Same author

Update of AUA guideline on the surgical management of female stress urinary incontinence.

The Journal of urology·2010
Same author

Oxybutynin and its new transdermal application for the treatment of overactive bladder.

Women's health (London, England)·2009

Area of Science:

  • Urology
  • Nephrology
  • Neuroscience

Background:

  • Impaired detrusor contractility (IDC) is a complex condition with varied etiologies, including neurological, inflammatory, and pharmacologic factors.
  • Current standard treatment, clean intermittent catheterization (CIC), is effective but impacts patient quality of life and carries risks like infections and injury.

Purpose of the Study:

  • To review and discuss emerging and innovative treatment options for impaired detrusor contractility.
  • To explore alternatives to clean intermittent catheterization (CIC) for managing IDC.

Main Methods:

  • Literature review of novel treatment modalities for IDC developed or tested in the last decade.
  • Categorization of treatments based on the target: nervous system, bladder, or bladder outlet.

Related Experiment Videos

Main Results:

  • The study identifies and discusses various new therapeutic approaches for IDC.
  • These novel treatments aim to improve bladder function and patient outcomes.

Conclusions:

  • Alternative treatment modalities for IDC are advancing, offering new hope for patients.
  • Further research and clinical testing are crucial for validating these novel IDC therapies.